Patients with active lupus nephritis ( n = 134 ) were enrolled in a randomized , double-blind phase II add-on trial in which they received either abatacept or placebo in conjunction with the Euro-Lupus Nephritis Trial regimen of low-dose cyclophosphamide ( CYC ) followed by azathioprine ( AZA ) .